Arvind Sathyamurthy (@Arvind_RadOnc) profile picture

Clinical Fellow in Gynaecologic Oncology,Royal Marsden Hospital London, Associate Professor of Radiation Oncology,CMC Vellore

Joined December 2021
Photo by Arvind Sathyamurthy (@Arvind_RadOnc)Photo by Arvind Sathyamurthy (@Arvind_RadOnc)
Arvind Sathyamurthy retweeted
This Independence Day 🇮🇳, I asked, "What will the next century of young Indians look like?" $0.01 Drone Deliveries. UAVs that never land. Groceries in under 10 minutes. Meet The 22nd Century Indian. A Documentary on a New India.
412
1,290
463
6,339
1,402,907
Arvind Sathyamurthy retweeted
Excited to share that our phase 2 trial #NeoLOCUS is now out in @LancetRH_SEAsia! A collective effort from the Head & Neck team @OffCMCVellore led by @todrashish We report R0 rates, ORR, safety, survival outcomes, tumor immune microenvironment change🧵👇 thelancet.com/journals/lanse…
5
11
5
41
11,036
We had a fantastic time celebrating our New Fellows during yesterday's Admission Ceremony! Congratulations once again on this momentous occasion 👏 #RCRFellows
6
2
30
2,395
Arvind Sathyamurthy retweeted
PRAGRAD, a new patient-driven treatment approach for very advanced oral cavity #cancers (which cannot be surgically removed) shows significant improvement in patient outcomes: prospective study by CMC #research team. Instead of a one-size-fits-all plan, #patients are given the choice of #palliative care or aggressive chemoradiation, promoting shared decision-making and #PatientAutonomy. It was found that when decision making was shared, more patients were willing to try aggressive chemoradiation; half the number who responded to initial #chemotherapy and continued aggressive treatment, survived over 30 months - 5 times longer than those choosing palliation (6 months). Nearly half survived beyond 2 years - a remarkable outcome for this advanced stage. Read more: doi.org/10.1016/j.ijrobp.202… @ASTRO_org #RedJournal #CancerCare #PatientChoice
14
4
49
3,466
Arvind Sathyamurthy retweeted
Quite the week for head&neck unit @royalmarsdenNHS 3 major outputs. bit.ly/3T0uS4p in @NEJM with Kevin Harrington bit.ly/45snlTq ION in @TheLancet Kate Newbold @DrChrisNutting and @IReC_RM consensus bit.ly/445yc3d in @JNCI_Now ThankYou collaborators
1
8
37
2,054
Arvind Sathyamurthy retweeted
💥 First practice-changing trial in over 2 decades for patients with resectable, LA HNSCC #AACR25 🌟EFS ITT 51 PembroSoC vs 30m SoC 🎯HR 0.73 (0.58-0.92) ⏱️OS inmature Congrats to all my colleagues at @royalmarsdenNHS H&N unit, rest of sites, sponsor💪@OncoAlert @brunolarvol
21
45
4,439
Arvind Sathyamurthy retweeted
We're hiring! Clinical Oncology Research Fellow opportunity at @royalmarsdenNHS @ICR_London to work on the landmark PACE trial & future prostate radiotherapy studies. Work with me, @EmmaHall71 @y_suhughes Join us! #OncologyJobs royalmarsden.nhs.uk/current-… @alison_tree @cpeedell
5
11
880
Arvind Sathyamurthy retweeted
congratulations 🎊 Very important findings, as we try to bring these expensive lifesaving treatment to people who can not afford to pay for the same.. @brunolarvol @FordePatrick @JCO_ASCO @OncoAlert @DrSanjayPopat
“When Less Is Truly More” Excited to share our work from Med Onc @OffCMCVellore published in @JCOGO_ASCO "Does adding low dose Nivo to NACT ⬆️response rates & survival in stage III non-oncogene-driven NSCLC?" 🔗doi.org/10.1200/GO-24-00256 Mentor @todrashish Key findings👇🧵#LCSM
4
8
1
41
3,027
Arvind Sathyamurthy retweeted
🧬🚨 New Study Alert! 🚨🧬 Our recent work dived into into BRCA1/2 mutations in India. There is limited data on population specific BRCA mutations in 🇮🇳. We used NGS to analyze 921 Indian women with suspected hereditary breast and ovarian cancer (HBOC). @OffCMCVellore #BRCA
2
14
1
47
4,906
Arvind Sathyamurthy retweeted
39th Annual #Conference of the Association of #RadiationOncologists of India (AROI), #TamilNadu & #Puducherry Chapter, organised by Dept of #Radiation #Oncology, Ida B Scudder #Cancer Centre, on 20th and 21st. Conference also marked 85th anniversary of the dept at #CMCVellore.
1
9
30
2,032
Arvind Sathyamurthy retweeted
#PACE A published in European Urology! SBRT vs Radical prostatectomy. Spread the word #SBRT should be discussed with eligible patients ⁦@DrTolan⁩ @alison_tree⁩ ⁦@cpeedell⁩ @DrAndrewLoblaw⁩ ⁦@EmmaHall71⁩ @ProfJOSullivan⁩ authors.elsevier.com/sd/arti… – at Kensington, London
8
108
15
218
54,706
Arvind Sathyamurthy retweeted
Radiation Oncology 101 this #NEETPG season for the uninitiated med student. Most MBBS grads in India come across #RadOnc for the very first time when preparing for NEETPG & a 4 hour lecture doesn't cut what we do in our sacred basements. Here is a primer to help you choose. 1/n
4
25
5
76
18,413
Arvind Sathyamurthy retweeted
🚨New Book on Low-Dose Radiation for Painful Musculoskeletal Conditions🚨 Free Download Now Available Over the past year, there has been a remarkable surge of interest in using low-dose radiotherapy to treat painful musculoskeletal conditions like osteoarthritis, plantar fasciitis, tendonitis, and bursitis. Many have inquired about how to initiate a program, secure institutional backing, leverage social media for promotion, and explore the supporting literature for these treatments. This interest inspired Dr. Richard Shaffer and me to author a book designed to assist radiation oncologists and administrators in launching such programs. The book will serve as an excellent supplement to a structured training program. ❇️ The book is now available. Click on the link below to download 👇 ❇️ All I request is for you to hit the repost button below so this can reach as many radiation oncologists as possible 👇 #radonc motivated-designer-9812.ck.p…
7
29
1
66
11,401
Arvind Sathyamurthy retweeted
1/ 📢 Excited to share our study led by @heberrewbright @todrashish & Sujith J Chandy(@ICARS_global) published in @JCOGO_ASCO investigating the role of capsaicin in⬇️CINV: an investigator-initiated RCT @ajoel_84 @ajoyojohn @divyathumaty @OffCMCVellore ascopubs.org/doi/full/10.120…
7
26
4
74
12,008
Arvind Sathyamurthy retweeted
Can MRI and CT Radiomics Predict Treatment Outcome in Rectal Cancer? Pre-treatment MRI with clinical features shows potential. Personalization strategies (e.g. aggressive Tx for high-risk, organ preservation for low-risk patients need accurate predictors. rdcu.be/dKrFt
1
2
2
101
Arvind Sathyamurthy retweeted
In addition to being a TV and media star, it turns out @VinPaleri is really rather good at #hnscc surgery.
#SuperSurgeon Professor Vin Paleri is appearing in this series of Super Surgeons on @Channel4. Sign up for our emails and get the latest updates: bit.ly/3xeerds
6
22
1,574
Kevin Harrington showing exciting clinical and preclinical data on modulating immune response at #ESTRO24‼️ Super impressive clinical responses to ATR inhibition + low dose #radiotherapy in HNSCC🔥 (cant post) @lauremarignol
3
14
43
3,385
Arvind Sathyamurthy retweeted
Dept of #Neonatology recently organised an 'NICU Graduates' Reunion' for premature babies who were under their care. More than 40 children with a birth weight of less than a kilo - currently between 2 and 5 years of age - participated along with their families.
1
13
1
70
2,836
Arvind Sathyamurthy retweeted
Our story of how the National Cancer Grid @CancerGridIndia drastically reduced costs of cancer care in India. A model that can (and should) be replicated in other disease areas and geographies. Economies of scale, assured quality, reduced stockouts (1/2) bbc.com/news/business-676787…
10
114
20
298
26,468
Arvind Sathyamurthy retweeted
Radiotherapy sentiment in @NYTimes is eye-opening. Since 2009, over half of articles show negative bias towards RT, while only 1/4 are positive. Despite major advancements in tech like MR-Linac, adaptive RT, & heavy ions, media celebration is scarce. thegreenjournal.com/article/… 1/7
9
65
11
164
138,019